CD4 and COVID-19: The expression levels of CD4, CD25 and FOXP3 showed a significant decrease in severe COVID-19 patients’ PBMC compared to controls (p < 0.0001, p = 0.01, p = 0.007, respectively) and CD patients (p < 0.0001 for all of them).